Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.09 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |